Results 71 to 80 of about 34,415 (160)

Microbial keystone taxa and metabolic signatures in centenarians regulate intestinal homeostasis during aging

open access: yesiMeta, EarlyView.
Clostridium scindens and its metabolite indole‐3‐acetic acid (IAA) are identified as a keystone taxon and metabolic signature in centenarians. Clostridium scindens enhances microbial network stability and produces IAA via its own amidase (AMIE) and aldehyde dehydrogenase (ALDH), thus promoting intestinal homeostasis by activating the aryl hydrocarbon ...
Wei‐Chuan Lin   +13 more
wiley   +1 more source

Meeting update: faecal microbiota transplantation––bench, bedside, courtroom? [PDF]

open access: yes, 2016
A group of stakeholders met, under the aegis of the British Society of Gastroenterology, to discuss the current landscape of faecal microbiota transplant- ation (FMT) within the UK and beyond.
Ding, N   +4 more
core   +1 more source

Multi‐omics biomarkers for intestinal infection and inflammation in inflammatory bowel disease: Current evidence, translational challenges, and diagnostic opportunities

open access: yesInterdisciplinary Medicine, EarlyView.
Prospective multi‐site cohorts, multi‐omics profiling, and computational analysis may help identify biomarker patterns across clinical settings in IBD and superimposed infections. With further mechanistic and clinical validation, these signals could support the development of practical multi‐analyte tools for more precise diagnosis and management ...
Ziyu Yang   +7 more
wiley   +1 more source

Decision aid reduces caregivers' preference for acid‐suppressive medication in infants with symptoms suggestive of reflux

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Caregivers of infants with symptoms suggestive of gastroesophageal reflux (GER), such as regurgitation and excessive crying, often feel uncertain and seek treatment, though it is usually unnecessary. This study evaluated the effect of a decision aid on reducing caregivers’ preference for acid suppressive medication for infants ...
Anna de Geus   +6 more
wiley   +1 more source

Cloning and Characterization of the Cell Wall Acting Enzyme CD1034 from the Pathogen Clostridium difficile [PDF]

open access: yes, 2012
The manifestation of multidrug resistance in bacteria over the past several decades has resulted in one of the foremost challenges in the management of infectious diseases.
Suter, Zachary
core   +1 more source

Ocular facial myositis and sialadenitis presenting with new onset ulcerative colitis

open access: yesJPGN Reports, EarlyView.
Abstract Extra‐intestinal manifestations of inflammatory bowel disease (IBD) can involve most organ systems, although the immunologic underpinnings are not well understood. Most patients who present with an extra‐intestinal manifestation have a single site of extra‐intestinal involvement; however, a small cohort presents with multiple different sites ...
Nicole Du, Nicole Mendez, Anil Darbari
wiley   +1 more source

Diarrhoea caused by Clostridium difficile in patients with postoperative subhepatic abscess [PDF]

open access: yes, 2008
Background. Toxigenic strains of Clostridium difficile in the majority of cases cause disease of the intestinal tract of hospitalized patients. For a long time, Clostridium difficile was considered to produce both types of toxins (A+/B+ strain), however,
Kocić Branislava, Stojanović Predrag
core   +1 more source

Epidemiology of Clostridium Difficile Infection [PDF]

open access: yesDeutsches Ärzteblatt international, 2015
According to L¨bbert et al., the incidence of Clostridium difficile infection (CDI) in Germany is 5 to 20 cases per 100 000 persons (1). It can be assumed that this figure is much too low. An ecological study based on routine data identified a total of 9874 cases hospitalized because of CDI, as well as further 26 341 cases with CDI as a concomitant ...
openaire   +2 more sources

The difficile in Clostridium difficile infection [PDF]

open access: yesInternational Journal of Infectious Diseases, 2018
Garabet, Akoghlanian, Seetha, Lakshmi
openaire   +2 more sources

Treatment of Clostridium difficile infection [PDF]

open access: yesJournal of Antimicrobial Chemotherapy, 1998
The treatment options for Clostridium difficile infection remain limited, although promising agents are currently being assessed. Metronidazole is the first-line drug of choice for those patients requiring specific anti-C. difficile treatment. Much of the interest in alternative therapies has centred on the difficult management issues posed by patients
openaire   +2 more sources

Home - About - Disclaimer - Privacy